1. Home
  2. WTM vs KYMR Comparison

WTM vs KYMR Comparison

Compare WTM & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WTM
  • KYMR
  • Stock Information
  • Founded
  • WTM 1980
  • KYMR 2015
  • Country
  • WTM Bermuda
  • KYMR United States
  • Employees
  • WTM N/A
  • KYMR N/A
  • Industry
  • WTM Property-Casualty Insurers
  • KYMR Medicinal Chemicals and Botanical Products
  • Sector
  • WTM Finance
  • KYMR Health Care
  • Exchange
  • WTM Nasdaq
  • KYMR Nasdaq
  • Market Cap
  • WTM 4.4B
  • KYMR 4.3B
  • IPO Year
  • WTM N/A
  • KYMR 2020
  • Fundamental
  • Price
  • WTM $1,901.43
  • KYMR $57.28
  • Analyst Decision
  • WTM
  • KYMR Strong Buy
  • Analyst Count
  • WTM 0
  • KYMR 19
  • Target Price
  • WTM N/A
  • KYMR $68.95
  • AVG Volume (30 Days)
  • WTM 26.5K
  • KYMR 656.4K
  • Earning Date
  • WTM 11-06-2025
  • KYMR 11-04-2025
  • Dividend Yield
  • WTM 0.05%
  • KYMR N/A
  • EPS Growth
  • WTM N/A
  • KYMR N/A
  • EPS
  • WTM 54.05
  • KYMR N/A
  • Revenue
  • WTM $2,603,700,000.00
  • KYMR $43,735,000.00
  • Revenue This Year
  • WTM N/A
  • KYMR $60.88
  • Revenue Next Year
  • WTM N/A
  • KYMR N/A
  • P/E Ratio
  • WTM $23.74
  • KYMR N/A
  • Revenue Growth
  • WTM N/A
  • KYMR N/A
  • 52 Week Low
  • WTM $1,648.00
  • KYMR $19.45
  • 52 Week High
  • WTM $2,023.00
  • KYMR $63.96
  • Technical
  • Relative Strength Index (RSI)
  • WTM 54.77
  • KYMR 48.00
  • Support Level
  • WTM $1,888.00
  • KYMR $55.66
  • Resistance Level
  • WTM $1,929.20
  • KYMR $61.21
  • Average True Range (ATR)
  • WTM 32.84
  • KYMR 3.02
  • MACD
  • WTM -6.57
  • KYMR -0.54
  • Stochastic Oscillator
  • WTM 45.89
  • KYMR 25.80

About WTM White Mountains Insurance Group Ltd.

White Mountains Insurance Group Ltd is engaged in the business of making opportunistic and value-oriented acquisitions of businesses and assets in the insurance, financial services, and related sectors, operating these businesses and assets through its subsidiaries and, if and when attractive exit valuations become available, disposing of these businesses and assets. The company conducts its business in five areas: property and casualty insurance and reinsurance, municipal bond reinsurance, capital solutions for asset and wealth management firms, property and casualty insurance distribution, and other operations.

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.

Share on Social Networks: